Short answer · Medically reviewed summary · Last updated: 2026-04-06
Hereditary Spastic Paraplegia is caused by mutations in over 80 different genes that disrupt the transport of essential materials within the longest nerve cells in the body, the corticospinal tract neurons. The Genetic Basis of Hereditary Spastic Paraplegia The primary cause of Hereditary Spastic Paraplegia (HSP) is genetic mutation. These mutations interfere with cellular "logistics"—the process by which nerve cells move proteins, organelles, and nutrients from the cell body down to the distant axon terminals.
4 people with Hereditary Spastic Paraplegia have shared their first-person experience on this question at DiseaseMaps.
Hereditary Spastic Paraplegia is caused by mutations in over 80 different genes that disrupt the transport of essential materials within the longest nerve cells in the body, the corticospinal tract neurons.
The primary cause of Hereditary Spastic Paraplegia (HSP) is genetic mutation. These mutations interfere with cellular "logistics"—the process by which nerve cells move proteins, organelles, and nutrients from the cell body down to the distant axon terminals. Think of these axons like long power cables; when the cellular transport system fails, the insulation and structure of the cable break down, leading to the progressive stiffness and weakness characteristic of Hereditary Spastic Paraplegia. Depending on the specific gene involved, the condition can be inherited in an autosomal dominant, autosomal recessive, or X-linked pattern.
While we have identified many of the genes responsible for Hereditary Spastic Paraplegia, such as SPAST (responsible for the most common form, SPG4), the underlying mechanisms are still a major focus of ongoing research. We currently understand that many of these genetic defects affect mitochondria (the cell's power plants) or the lipid metabolism within the cell membrane. Unlike some conditions where environmental triggers play a major role, Hereditary Spastic Paraplegia is primarily determined by one's genetic blueprint. It is crucial to distinguish between a "cause"—the specific genetic mutation—and a "risk factor." In this context, there are no known environmental exposures that "cause" the disease; rather, the risk is determined entirely by inheritance. Ongoing research is currently exploring gene therapy and small-molecule drugs aimed at restoring axonal transport, offering hope for future interventions.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.